A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin.
about
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesKaposi's Sarcoma Herpesvirus Genome PersistenceA Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA ProteinsComprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistenceHHV-8 encoded LANA-1 alters the higher organization of the cell nucleus.Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.Phosphorylation of the chromatin binding domain of KSHV LANAKSHV LANA--the master regulator of KSHV latency.Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.Kaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency.Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANAThe ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNALANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection.The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle.The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.The chromatin landscape of Kaposi's sarcoma-associated herpesvirus.Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif.Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
P2860
Q24673761-E43A29A6-2BBF-4CF9-9298-E994E0A48D2EQ26738483-912E7923-3F5B-44F1-A2AA-3D3A66EB8310Q27680409-79AE50E9-5278-433F-A7FE-8D672E092B05Q28533244-20EC964D-04C4-451E-A2BB-2D24F9FF9B40Q30479353-75BC93B5-4215-44F5-8B90-C523EA6A953FQ33221441-09DDBB92-74F0-4A6C-A15D-C8F747C69BABQ33781363-EF7A22F3-A61D-4A3E-9E2A-EE2F0275C015Q34092739-C4870042-9284-4338-B575-4504F7E15A9BQ34192731-96839484-8F75-4E13-B216-5D5E2D62644EQ34292265-8E4F1C76-B8C7-421F-8A1D-F934A3FCCEF4Q34456086-0CFF9861-1583-4E10-B7F8-E9F9AECC1857Q34774797-72509785-1218-417D-9605-8BD88DF87273Q35139294-585AD2EB-39E9-402E-BD05-C85FE5AE508EQ35208258-60E0E51F-71AB-40D7-9909-2F0ED62B7038Q35691156-FC1B821B-FEA1-41B8-9325-945948311EDBQ35785433-C0007ED0-E7F1-4577-9871-9164C8ECB927Q35943531-6AE14B09-1823-47A4-86DA-B415F44FC1BFQ36086767-9104EDA7-86B0-43E1-8B9C-C71F36C7B4AEQ36126100-931FC89B-DC2F-4B14-B673-7F89C3665DE1Q36994613-232D923C-2107-4938-A86C-F093E3BF1AB1Q37030691-68D4E16A-0CD6-445D-9F6C-29FEE24E02DAQ37157234-57207EEF-E377-474B-8F99-16F9BF26FE62Q38108700-3577FD5D-A0E5-4191-BC15-423B045B2D4EQ38449592-D2EA31D4-AD33-4FE9-AFC8-82458BBDBFB6Q39744147-08874290-E578-48FB-A903-4E6299974C30Q39960021-8223782C-8FD7-443E-8D46-888123DA21F8Q40163096-44B5D490-A9C3-43D9-8DB6-1E71B4353B67Q44703163-1F7F52BF-D7B4-4B4F-B204-841A913FBCCF
P2860
A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@en
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@nl
type
label
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@en
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@nl
prefLabel
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@en
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@nl
P2093
P2860
P1433
P1476
A Domain in the C-terminal reg ...... ng to nuclear heterochromatin.
@en
P2093
Abel Viejo-Borbolla
Emrah Kati
Karin Mattsson
Kavita Nathan
Thomas F Schulz
P2860
P304
P356
10.1128/JVI.77.12.7093-7100.2003
P407
P577
2003-06-01T00:00:00Z